Browse 37 market data Tables and 66 Figures spread through 115 Pages and in-depth TOC on "Bioreactors Market by Scale Range (20L, 1500L), Material (Single-Use, Stainless Steel), Usage (Lab Scale, Pilot Scale, Full Scale), Suppliers (OEMs, EPCs), End-User (R&D Departments, Biopharmaceutical Manufacturers), Region - Global Forecast to 2021"
Early buyers will receive 10% customization on reports.
The bioreactors market is estimated to grow at a CAGR of 6.8% from 2016 to 2021 to reach USD 1,417 Million by 2021. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2016 and 2022. In the current market scenario, the increase in adoption of single-use technologies, use of hybrid technologies: Single-use and Stainless Steel, and growing biologics market are propelling the growth of the bioreactors market. The objective of this report is to define, describe, and forecast the market on the basis of usage, scale, material, control type, end-user and region. It provides detailed information regarding the major factors influencing the growth of the market. Drivers, restraints, opportunities, challenges, and trends in the market have also been taken consideration while preparing this report. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, market share analysis, and financials.
Top-down and bottom-up approaches were used to validate the size of the global bioreactors market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred are U.S. Food and Drug Administration, Bioprocess International, Biopharma International Supplement, Pharmaceutical Technology Europe, and The World Bank.
The major OEM/system integrator players included in this report are Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher Corporation (U.S), Eppendorf AG (Germany), and major EPC players included in this report are Amec Foster Wheeler plc (U.K.), Fluor Corporation (U.S.), Jacobs Engineering Group Inc. (U.S.), M+W Group (Germany), PM Group (Ireland), and Technip S.A. (France).
For more information, visit: https://www.marketsandmarkets.com/Market-Reports/bioreactor-market-59253123.html